BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodailynews.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260515
DTEND;VALUE=DATE:20260517
DTSTAMP:20260603T062800
CREATED:20260104T234351Z
LAST-MODIFIED:20260104T234406Z
UID:10000549-1778803200-1778975999@oncodailynews.com
SUMMARY:ESMO Preceptorship on Colorectal Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Colorectal Cancer 2026: Lugano is a specialized educational course scheduled for May 15–16\, 2026\, in Lugano\, Switzerland. \nThis course is designed to provide oncologists – particularly young and general oncologists – with a comprehensive understanding of colorectal cancer management from diagnosis to treatment. The technical program includes plenary lectures by international experts and interactive case-based sessions\, covering best practices in multidisciplinary management for both adjuvant and metastatic settings\, the role of molecular pathology in prognosis\, and the optimal sequencing of systemic therapies. \nSuccessful applicants benefit from complimentary registration and accommodation\, and the event is accredited with 9 ESMO-MORA category 1 points. \nApplication.
URL:https://oncodailynews.com/event/colorectal-cancer-2026-436774
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/01/ESMO-Preceptorship-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260513
DTEND;VALUE=DATE:20260515
DTSTAMP:20260603T062800
CREATED:20260104T001901Z
LAST-MODIFIED:20260104T001917Z
UID:10000548-1778630400-1778803199@oncodailynews.com
SUMMARY:ESMO Preceptorship on Head and Neck Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Head and Neck Cancer 2026 is a specialized educational course scheduled for May 13–14\, 2026\, in Lugano\, Switzerland. \nThis program is designed to provide medical and clinical oncologists with a deep understanding of the management of head and neck cancers\, ranging from diagnosis to advanced treatment strategies. The curriculum covers the epidemiology\, etiology\, and molecular biology of nasopharyngeal cancer (NPC) and head and neck squamous cell carcinoma (HNSCC). \nParticipants will explore multidisciplinary management approaches\, including the roles of surgery\, radiation therapy\, and systemic therapy\, with a particular emphasis on the integration of immunotherapy and the management of rare tumors. The course combines plenary lectures with interactive\, case-based sessions to facilitate direct engagement between participants and international experts. Successful applicants receive complimentary registration and accommodation\, and the event is accredited with 11 ESMO-MORA category 1 points. \nApplication.
URL:https://oncodailynews.com/event/head-and-neck-cancer-436369
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/01/ESMO-Preceptorship-on-Head-and-Neck-Cancer.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260511
DTEND;VALUE=DATE:20260513
DTSTAMP:20260603T062800
CREATED:20260104T001332Z
LAST-MODIFIED:20260104T001344Z
UID:10000547-1778457600-1778630399@oncodailynews.com
SUMMARY:ESMO Preceptorship on Hereditary Cancer Genetics 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Hereditary Cancer Genetics 2026 is an intensive educational course scheduled for May 11–12\, 2026\, in Lugano\, Switzerland. \nCo-chaired by Judith Balmaña and Marjolijn Ligtenberg\, this program is designed to provide oncologists with a comprehensive understanding of the molecular basis of genetic susceptibility to cancer. The technical curriculum focuses on the multidisciplinary management of hereditary cancer syndromes\, the identification and diagnosis of germline genetic mutations\, and the implementation of evidence-based prevention strategies. \nThrough a combination of state-of-the-art lectures and interactive clinical case discussions\, the course aims to equip participants with the skills necessary to provide personalized care for patients with hereditary cancer risks. Successful applicants benefit from complimentary registration and accommodation\, and the event is accredited with 9 ESMO-MORA category 1 points. \nApplication.
URL:https://oncodailynews.com/event/hereditary-cancer-genetics-436366
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/01/ESMO-Preceptorship.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260220
DTSTAMP:20260603T062800
CREATED:20251126T002120Z
LAST-MODIFIED:20251126T002132Z
UID:10000403-1771372800-1771545599@oncodailynews.com
SUMMARY:ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer\, providing oncologists with a thorough understanding of current standards of care\, molecular pathology\, and novel treatment targets. \nThe preceptorship will take place on February 18–19\, 2026\, in Lugano\, Switzerland\, and is accredited with ESMO-MORA category 1 points. Successful applicants receive complimentary course registration and accommodation. The application deadline for this event is December 11\, 2025. \nApply.
URL:https://oncodailynews.com/event/esmo-preceptorship-416470
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2025/11/esmo-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251216
DTEND;VALUE=DATE:20251218
DTSTAMP:20260603T062800
CREATED:20251124T213007Z
LAST-MODIFIED:20251124T213103Z
UID:10000399-1765843200-1766015999@oncodailynews.com
SUMMARY:ESMO Preceptorship on Prostate Cancer 2025: Lugano
DESCRIPTION:The ESMO Preceptorship on Prostate Cancer 2025: Lugano is a two-day educational course focusing on a thorough understanding of prostate cancer management\, from diagnosis to treatment\, according to current standards of care. \nOrganized by the European Society for Medical Oncology (ESMO)\, the event is scheduled to take place on December 16–17\, 2025\, in Lugano\, Switzerland. The preceptorship is designed primarily for medical and clinical oncologists\, especially young oncologists\, and has been accredited for 9 ESMO-MORA category 1 points.
URL:https://oncodailynews.com/event/preceptorship-on-prostate-cancer-415823
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodailynews.com/pub/uploads/2025/09/1756803627507.jpeg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR